RxSight Reports Q3 Adjusted EPS Below IBES Estimate
RxSight reported Q3 adjusted net income of USD -8.6 million.
Related stories
Amgen lifts 2026 profit and revenue forecast; shares fall
Amgen raised its 2026 profit and revenue forecasts, while its shares fell.
M impact | EARNINGS | Nov 03, 2026, 10:01 PM UTC
Banorte erwartet 2026 Nettogewinn von 62 bis 64 Milliarden Pesos
M impact | EARNINGS | Nov 03, 2026, 09:51 PM UTC
BB Seguridade Projects Brasilseg Premiums Written Down in 2026
M impact | EARNINGS | Nov 03, 2026, 09:51 PM UTC
Bristow Group Sees FY Adjusted EBITDA of $300–320 Million
M impact | EARNINGS | Nov 03, 2026, 09:50 PM UTC
CTT Reports Nine-Month Revenue of EUR 994.7 Million
L impact | EARNINGS | Nov 03, 2026, 09:50 PM UTC
Accel Entertainment Reports LTM Adjusted EBITDA of $220 Million
M impact | EARNINGS | Nov 03, 2026, 09:50 PM UTC